The association of well-being, productivity and resource use among community-dwelling patients with schizophrenia using atypical antipsychotics

被引:2
作者
DiBonaventura, Marco Dacosta [1 ]
Panish, Jessica
Kenworthy, Debbie [2 ]
Wagner, Jan-Samuel [2 ]
Dirani, Riad
机构
[1] Kantar Hlth, New York, NY USA
[2] Ortho McNeil Janssen Sci Affairs LLC, Titusville, NJ USA
关键词
atypical antipsychotics; healthcare resource use; schizophrenia; well-being; productivity;
D O I
10.1111/j.1759-8893.2010.00033.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective The aim of the current study was to examine levels of well-being and productivity and the interrelationships between them in community-dwelling patients with schizophrenia who use atypical antipsychotic medications. Methods A mixed methodology (online and paper surveys) was implemented to recruit patients in the USA over the age of 18 years who were diagnosed with schizophrenia by a healthcare professional and who were able to read and write English. Patients who were currently being treated with an atypical medication and provided well-being data (n = 745) were included in the analyses. Logistic and negative binomial regressions were used to determine the effect of well-being on productivity and resource use. Key findings Almost two-thirds of patients taking atypical antipsychotics reported low levels of well-being (63%). After controlling for demographic and patient characteristics, patients with low levels of well-being were significantly less likely to be employed and productive than patients with moderate or high levels of well-being (P < 0.05). Similarly, patients with low levels of well-being were significantly more likely to be hospitalized or visit the emergency room relative to patients with high levels of well-being (P < 0.05). Conclusions The results suggest that there may be an unmet need among patients with schizophrenia who use atypical antipsychotic medications. Overall levels of well-being were low in these community-dwelling patients. Further, low levels of well-being were found to be significantly related to worse productivity and, to a certain extent, additional resource use, after controlling for a variety of confounding variables. Although additional research is necessary, improved disease management and use of innovative antipsychotic medications, such as long-acting injectables, may benefit these patients by improving well-being, productivity and resource use.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 22 条
  • [1] Is quality of life associated with cognitive impairment in schizophrenia?
    Alptekin, K
    Akvardar, Y
    Akdede, BBK
    Dumlu, K
    Isik, D
    Pirinçci, F
    Yahssin, S
    Kitis, A
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (02) : 239 - 244
  • [2] American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th., DOI DOI 10.1176/APPI.BOOKS.9780890425787
  • [3] Bagnall A-M, 2003, Health Technol Assess, V7, P1
  • [4] Quality of life in schizophrenia: A comparison of instruments
    Cramer, JA
    Rosenheck, R
    Xu, WC
    Thomas, J
    Henderson, W
    Charney, DS
    [J]. SCHIZOPHRENIA BULLETIN, 2000, 26 (03) : 659 - 666
  • [5] A meta-analysis of the efficacy of second-generation antipsychotics
    Davis, JM
    Chen, N
    Glick, ID
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (06) : 553 - 564
  • [6] Dixon L, 2009, APA PRACTICE GUIDELI
  • [7] Dupuy HJ., 1984, ASSESSMENT QUALITY L, P170
  • [8] Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
    Geddes, J
    Freemantle, N
    Harrison, P
    Bebbington, P
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7273): : 1371 - 1376
  • [9] Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
    Jones, Peter B.
    Barnes, Thomas R. E.
    Davies, Linda
    Dunn, Graham
    Lloyd, Helen
    Hayhurst, Karen P.
    Murray, Robin M.
    Markwick, Alison
    Lewis, Shon W.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (10) : 1079 - U6
  • [10] The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
    Keefe, RSE
    Silva, SG
    Perkins, DO
    Lieberman, JA
    [J]. SCHIZOPHRENIA BULLETIN, 1999, 25 (02) : 201 - 222